Status:
RECRUITING
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
20+ years
Brief Summary
This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.
Detailed Description
Colorectal cancer (CRC) is the third most common cancer worldwide. The clinical outcomes from CRC treatments are often unsatisfactory for the majority of patients. The tumor microenvironment (TME) pla...
Eligibility Criteria
Inclusion
- Aged 20 years and older.
- Patients who have been given a diagnosis of colorectal cancer.
- Patients had previously initiated anti-cancer therapies between January 1, 2020, and Apr 30, 2024.
Exclusion
- None
Key Trial Info
Start Date :
August 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06557668
Start Date
August 20 2024
End Date
April 1 2025
Last Update
August 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung-Shan Medical University Hospital
Taichung, Taiwan
2
Taichung Veterans General Hospital
Taichung, Taiwan